ArticleClinical and molecular hepatology2026

Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: Editorial on "High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease".

Ho Soo Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.